Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)
Clinical trial NCT01479764 · COMPLETED
Trial details
- NCT number
- NCT01479764
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-02
- Primary completion
- 2012-10-26
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.